Literature DB >> 30277091

Grade II Sylvian fissure meningiomas without dural attachment: case report and review of the literature.

Christian Brogna1,2, José Pedro Lavrador1, Sabina Patel1, Eduardo C Ribas3, Miren Aizpurua4, Francesco Vergani1, Keyoumours Ashkan1, Ranjeev Bhangoo1.   

Abstract

Sylvian fissure meningiomas (SFMs) represent a rare subgroup of nondural-based tumors arising from the meningothelial cells within the arachnoid of the Sylvian fissure. SFMs are more frequent in young males, usually manifest with seizures and display the same radiological features of meningiomas in other locations. Although the absence of dural attachment makes these tumors suitable for a complete resection, their anatomical relationships with the middle cerebral artery branches have impaired its achievement in half of them. To the best of our knowledge, only five atypical WHO grade II SFMs have been previously described. We provide a literature review of SFMs WHO grades I-II and discuss common characteristics and surgical challenges we found in a similar case.

Entities:  

Keywords:  Sylvian fissure; atypical meningiomas; dural attachment; meningioma

Mesh:

Year:  2018        PMID: 30277091      PMCID: PMC6331700          DOI: 10.2217/cns-2018-0004

Source DB:  PubMed          Journal:  CNS Oncol        ISSN: 2045-0907


Sylvian fissure meningiomas are rare nondural-based lesions. Sylvian fissure meningiomas are more common in males and usually present with seizures. The anatomical relationship with the middle cerebral artery has prevented complete resections in the described cases. Preoperative vascular imaging and intraoperative angiography may improve surgical planning and safe complete tumoral resection rates. Meningiomas are thought to arise from the meningothelial cells within the arachnoid and are typically recognized by their attachment to the dura. These cells can also be found in the choroid plexus and tela choroidea, which can explain why meningiomas may rarely occur in other locations without dural attachment. In the absence of dural attachment, they are categorized into intraventricular, pineal region, intraparenchymal, subcortical and deep Sylvian fissure meningiomas (SFMs) [1]. Meningiomas are most commonly supplied by dural arteries arising from external carotid system, but may develop a secondary supply via the pial arteries, such as the branches of the anterior, middle and posterior cerebral arteries from the internal carotid and vertebrobasilar systems [2]. Atypical meningiomas WHO grade II account for 5–7% of all meningiomas and have a higher likelihood of recurring as they proliferate at a higher rate and can invade the brain [3]. As the role of complementary treatment is yet to be defined, the surgical approach and the extent of resection is of paramount importance in the prognosis. In those cases where no dural attachment is found, a complete resection of the tumor may represent the cure for these patients. The authors discuss a patient with an atypical WHO grade II SFM without dural attachment and review the previous literature centered on clinical, radiological, pathologic characteristics and treatment approach of this rare condition.

Case report

A 32-year-old right-handed charity worker with no significant past medical history presented with a year-long history of daily bitemporal and frontal headaches. The headaches were associated with dizziness and unsteadiness as well as nausea, phonophobia and photophobia. These symptoms then progressed in a month affecting the patient's activities of daily living. There was no associated history of seizures, speech disturbance or sensory/motor deficits and the neurological exam was unremarkable. A computed tomography head and angio-computed tomography identified an hyperdense lesion in the left temporal convexity in close relation with the Sylvian fissure (M2 branches from left MCA) and the MRI-revealed and homogenous contrast-uptake lesion, consistent with a meningioma (Figure 1). A left pterional craniotomy was performed and, as soon as the dura was opened, it became evident that the tumor did not have any convexity or skull-based dural attachment. Proximal microsurgical opening of the Sylvian fissure was performed starting at the anterior Sylvian point, exposing the carotid artery for proximal control. Internal debulking of the tumor followed by gentle dissection of the capsule all along the arachnoidal plane from the surrounding brain parenchyma was performed while preserving the temporal M2 and M3 branches. However, a clear attachment of the meningioma to the arachnoid overlying the most anterior portion of the posterior insular gyrus became evident, and it was was dissected and coagulated. In fact, while a clear arachnoidal plane was identified all around the meningioma, an exception was made by the portion of the tumor facing the posterior insular gyrus (Figure 2).

Pre-operative imaging.

Axial-CT head with contrast (A and B) and axial (C) and coronal (D) MRI T1-weighted images with gadolinium revealing a homogenously enhancing left pterional region tumor. Axial angio-CT head (E) and 3D angio-reconstruction (F) revealing the intrinsic relationship in between the left MCA branches and the lesion.

CT: Computed tomography; MCA: Middle cerebral artery; MRI: Magnetic resonance impaging; T1: Superior temporal gyrus.

Intraoperative imaging and schematic review.

Intraoperative photos before (A) and after (B) microsurgical resection of the SFM and correlation with an anatomical specimen with the same operative angle (C). (A) shows the clear absence of any dural attachment of the SFM. (B) shows the AA of the Sylvian fissure meningioma in correspondence of the anterior part of the posterior long insular gyrus. (C) The Sylvian fissure is opened and the relationships of the middle cerebral artery branches with the surrounding anatomical structures is unveiled.

AA: Arachnoidal attachment; SFM: Sylvian fissure meningioma.

Pre-operative imaging.

Axial-CT head with contrast (A and B) and axial (C) and coronal (D) MRI T1-weighted images with gadolinium revealing a homogenously enhancing left pterional region tumor. Axial angio-CT head (E) and 3D angio-reconstruction (F) revealing the intrinsic relationship in between the left MCA branches and the lesion. CT: Computed tomography; MCA: Middle cerebral artery; MRI: Magnetic resonance impaging; T1: Superior temporal gyrus.

Intraoperative imaging and schematic review.

Intraoperative photos before (A) and after (B) microsurgical resection of the SFM and correlation with an anatomical specimen with the same operative angle (C). (A) shows the clear absence of any dural attachment of the SFM. (B) shows the AA of the Sylvian fissure meningioma in correspondence of the anterior part of the posterior long insular gyrus. (C) The Sylvian fissure is opened and the relationships of the middle cerebral artery branches with the surrounding anatomical structures is unveiled. AA: Arachnoidal attachment; SFM: Sylvian fissure meningioma. The histological staining identified atypical features within the tumor specimens. There were areas of hypercellularity with small nuclei and areas of necrosis, but no evidence of increased mitotic activity and a low-proliferating index. The features were consistent with an atypical meningioma, WHO grade II. (Figure 3). The postoperative course was uneventful. The patient reported a consistent improvement in his headaches in the next days following the surgery. A follow-up MRI at 3 months did not reveal any recurrence of the tumor and the patient is under clinical and radiological surveillance with no signs of recurrence at 3 years’ follow-up (Figure 4).

Histology.

Haematoxylin and eosin (A–C) revealing an atypical meningioma with a characteristic diffuse arrangement in sheets (A). Areas of small cell changes (B) and tumor necrosis (C). (D) Estimated proliferation index of 6–7% stained by Ki67.

Post-operative imaging.

3 months postoperative axial (A), coronal (B) and sagittal (C) T1-weighted MRI with gadolinium showing total resection of the meningioma and no signs of recurrence.

MRI: Magnetic resonance imaging; T1: Superior temporal gyrus.

Histology.

Haematoxylin and eosin (A–C) revealing an atypical meningioma with a characteristic diffuse arrangement in sheets (A). Areas of small cell changes (B) and tumor necrosis (C). (D) Estimated proliferation index of 6–7% stained by Ki67.

Post-operative imaging.

3 months postoperative axial (A), coronal (B) and sagittal (C) T1-weighted MRI with gadolinium showing total resection of the meningioma and no signs of recurrence. MRI: Magnetic resonance imaging; T1: Superior temporal gyrus.

Discussion

Cushing and Eisenhardt originally classified meningiomas without dural attachment in intraventricular, subcortical and deep Sylvian [4]. Nowadays, meningiomas without dural attachments are classified in supratentorial (intraventricular, intraparenchymal or subcortical, pineal region, deep Sylvian) and infratentorial (intraventricular, inferior tela choroidea, cisterna magna and intraparenchymal) [5]. The most common lesions in this group occur in pediatric population and have an infratentorial location [6]. SFMs are rare entities and it is important to differentiate them from the sphenoid wing meningiomas. These are attached to the dura overlying the sphenoid wings, are usually associated with hyperostosis and they displace the MCA backwards as they grow, while the SFMs do not have dural attachment, do not produce hyperostosis and grow inbetween the MCA branches. Given the recent changes in the meningioma classification system, it is difficult to comment on the grades inbetween these locations, even though the literature presented suggests a higher proportion of grade II lesions among the SFMs [6]. Barcia–Goyanes et al. [7] described the first case in 1953, and since then only 28 cases (including the present report) have been described (Tables 1, 2 and 3). [8-26] The reported adult SFMs patients are young (mean age of 34.95 ± 3.35 years; 95% CI [27.93–41.97]) with a M:F ratio of 1.22 (11/9) and in the pediatric population (mean age is 5.71 ± 1.61 years; 95% CI [1.76-9.66]; the M:F ratio is 2:1 (4/2 and 1 unknown). When comparing grade I and grade II lesions, there is no significant differences in terms of mean age (grade I: 26.87 ± 3.90 years; vs grade II 24.33 ± 7.01 years; t-test p > 0.05), gender (grade I M:F ratio – 1.2 [12/10] versus grade II M:F ratio – 5 [5/1)]), clinical presentation (seizures is the most common presentation in both groups – grade 1 – 74% (17/23) and grade II – 67% (4/6)] and extent of resection (total resection in grade 1 – 65% [1/23] and total resection in grade II – 50% [3/6]. (Table 4)

Summary of the WHO grade I Sylvian fissure meningiomas in adult patients reported in the literature.

Study [Ref.] (year)Age/genderPresenting symptomsMRI T1MRI T2CT scanVascular imagingExtent of resectionVascular supplyHistologyOutcome
Barcia-Goyanes et al. [7] (1953)20/FSeizuresNot performedWHO grade I (psamommatous)

Cushing and Eisenhardt (1969) [4]18/MSeizuresNot performedPartialMCAWHO grade I (psamommatous)3 recurrences (5 years of survival)

 48/FSeizuresNot performedPartialWHO grade I (psamommatous)Died on the day of surgery 

Mori et al. [23] (1977)23/MSeizuresNot performedPartialWHO grade I (transition)

Saito et al. [26] (1979)31/FSeizuresHyperdense lesionVascular blushing from internal carotidTotalWHO grade I (psamommatous)

Tsuchida et al. [27] (1981)46/MHeadacheVascular blushing from internal carotidTotalMCAWHO grade I (meningothelial)

Okamoto et al. [25] (1985)27/FHeadache and visual disturbancesTotalWHO grade I (fibroblastic)5 years of survival

 35/FSeizuresHyperdense with homogeneous with contrast enhancement and oedemaVascular blushing from internal carotidTotalMCAWHO grade I (fibroblastic)

Hirao et al. [15] (1986)34/FSeizuresHyperdense with homogeneous with contrast enhancementVascular blushing from internal carotidTotalWHO grade I (fibroblastic)

Graziani et al. [14] (1992)19/MHeadache, memory disturbances and hemiparesisHypoHyperdense with calcifications with contrast enhancement and edemaVascular blushing from internal carotidTotalMCAWHO grade I (psamommatous)

Chiocca et al. [1] (1994)26/FSeizuresHypoHypoHyperdense with homogeneous with contrast enhancement and edemaVascular blushing from internal carotidTotalNo attachmentWHO grade I (fibrous)

Matsumoto et al. [20] (1995)62/FSeizuresHypoHypoCalcified massVascular blushing from internal carotidTotalMCAWHO grade I (psamommatous)

Chang et al. [9] (2005)35MSeizuresIsoIso (edema)No vascular blushingPartialMCAWHO grade I (transition)

Eghwrudjakpor et al. [12] (2006)73FNonspecific symptomsHeterogenous tumorWHO grade I (meningothelial)

Aras et al. [8] (2012)28M4 m complex partial seizuresHypoIso/HypoNo TotalMCAWHO I meningothelialNo

Kim et al. [17] (2013)43MNew onset seizureIsoIsoNo PartialWHO grade INo

CT: Computed tomography; F: Female; M: Male; MCA: Middle cerebral artery; MRI: Magnetic resonance imaging; WHO: World Health Organization.

Summary of the WHO grade I Sylvian fissure meningiomas in pediatric patients reported in the literature.

Study (year)Age/genderPresenting symptomsMRI T1 T2 CT scanVascular imagingExtent of resectionVascular supplyHistologyRecurrence
Silbergeld et al. [28] (1988)4FSeizures Homogeneously enhancing masVascular blushing from internal carotidPartialMCAWHO grade I (meningothelial)

Cho et al. [10] (1990)2MSeizures and hemiparesis Heterogeneous hyperdense with contrast enhancement and edemaVascular blushing from internal carotidTotalWHO grade I (transition)2 years; no recurrence

Mori et al. [24] (1994)12MIntracranial hypertensionContrast enhancing tumoeedemaHyperdense with homogeneous with contrast enhancement and edemaTotalMCAWHO grade I (transition)1 year; no recurrence

Mitsuyama et al. [22] (2000)1/–SeizuresContrast enhancement lesionContrast enhancement lesionContrast enhancement lesionVascular blushing from internal carotidTotalMCAWHO grade I (fibrous)

Kumar et al. [18] (2009)6M4-year complex partial seizureHypoHyperHomogeneously enhancing mas with contrast enhancementNoTotalMCAWHO grade INo

Aras et al. [8] (2012)15M2-year complex partial seizuresHypoIso/HypoHomogeneously enhancing mas with contrast enhancementNoTotal over staged surgeryMCAWHO I fibroblastic typeNo

Fukushima et al. [13] (2013)10M3-year seizuresHomogeneously enhancing mas with contrast enhancementNoTotalMCAWHO I sclerosingNo

CT: Computed tomography; F: Female; M: Male; MCA: Middle cerebral artery; MRI: Magnetic resonance imaging; WHO: World Health Organization.

Summary of the WHO grade II Sylvian fissure meningiomas in pediatric and adult patients reported in the literature.

Study (year)Age/genderPresenting symptomsMRI T1 T2 CT scanVascular imagingExtent of resectionVascular supplyHistologyOutcome
Cooper et al. [11] (1997)4/MIntracranial HypertensionIsoIso/HypoHyperdense with homogeneous with contrast enhancement and edemaVascular blushing from internal carotidTotalWHO IINo

Kaplan et al. [16] (2002)11/FSeizuresIsoIso/Hypo TotalMCAWHO II

McIver et al. [21] (2005)23/MSeizuresIso/HypoIso/Hypo PartialMCAWHO II chordoidNo

Cecchi et al. [6] (2008)23/MSeizuresIso/HypoIso/HypoHeterogenous tumor with edemaVascular blushing from internal carotidPartialM2Atypical WHO IIStable residual tumor at 2 years of follow-up

Ma et al. [19] (2012)53/MSeizures  PartialMCAAtypical WHO IINo

Present case (2015)32/MHeadaches and dizzinessIsoIso Angio-CTTotalMCA (M2)Atypical WHO IINo recurrence

Bold information highlights the present case report in this paper.

CT: Computed tomography; F: Female; M: Male; MCA: Middle cerebral artery; MRI: Magnetic resonance imaging; WHO: World Health Organization.

Demographic and clinical characteristics of the Sylvian fissures meningiomas reported in the literature.

CharacteristicSubcharacteristicWHO Grade IWHO Grade II
Mean age (years) 26.87 ± 3.9024.33 ± 7.01

Gender (pediatric and adult population)Male Female Ratio (M/F)12 10 1.25 1 5

SymptomsSeizures Headaches Intracranial hypertension17 5 14 1 1

Extent of ressectionPartial Total6 153 3

Total236

F: Female; M: Male; SFM: Sylvian fissure meningioma; WHO: World Health Organization.

CT: Computed tomography; F: Female; M: Male; MCA: Middle cerebral artery; MRI: Magnetic resonance imaging; WHO: World Health Organization. CT: Computed tomography; F: Female; M: Male; MCA: Middle cerebral artery; MRI: Magnetic resonance imaging; WHO: World Health Organization. Bold information highlights the present case report in this paper. CT: Computed tomography; F: Female; M: Male; MCA: Middle cerebral artery; MRI: Magnetic resonance imaging; WHO: World Health Organization. F: Female; M: Male; SFM: Sylvian fissure meningioma; WHO: World Health Organization. When considering the WHO grade II atypical meningiomas, only six lesions have been described (considering the present report; Table 3) [6,9,11,16,21]. Atypical meningiomas constitute 20% of the meningiomas in these region, higher than in other locations (5–7%) as it has already been noted by Cecchi et al. [6]. Regarding its epidemiology, there is a clear male predominance (5/6) although there is no gender prevalence when considering all the SFMs; 5/6 patients are aged below 32 years old. When considered together, male gender and younger aged are risk factors for WHO grade II histological differentiation in other locations, which is also true in this location [6]. Therefore, there are no sufficient data published that allow assessing if the Sylvian fissure location is a risk factor for WHO grade II lesions per se or if it has been confounded by these previously known epidemiological risk factors. Even though absent in the present case, seizures is the most frequent symptom which is believed to be related either with the temporal location and with the fact that WHO grade II tumors might show adjacent brain invasion as part of their diagnostic criteria. Surprisingly, considering its location and the histological nature of these lesions, no focal motor deficits were reported as initial symptoms. In terms of radiological appearance, and if the dural tail is not considered as part of their definition, these lesions display the same features of meningiomas in other regions of the central nervous system. When considering the treatment approach, the absence of dural attachment is attractive in terms of complete surgical resection. Nevertheless, the intimate relation with the MCA vessels has been an important predictor of incomplete resection (3/6). A preoperative vessel imaging may help to define the vascular anatomy and the relation between the tumor and the vascular system allowing a better surgical planning. Even though a higher degree of complete resections were obtained in patients with preoperative vascular imaging (2/3 vs 1/3), the numbers do not allow the drawing of definitive conclusions. The intraoperative use of indocyanine green might be important as a tool for an appropriate identification of the main vessels and the tumor feeders allowing a safer dissection. In those cases, where complete surgical resection was not possible due to intraoperative findings or it was not planned due to preoperative imaging information, we consider that postoperative radiotherapy should be considered, as suggested by recent ongoing trials [29].

Conclusion

WHO grade II SFMs are a rare subgroup of supratentorial meningiomas. Young males represent the predominant group. Seizures are the most frequent symptom. Imaging shows no dural tail in a background of other common features for meningioma. Surgical treatment is the mainstay of therapy. However, these lesions usually display adherence to the MCA which makes it more difficult to achieve a complete resection. When incomplete resection is performed, postoperative radiotherapy may be considered.

Future perspective

Grade II SFM surgery is technically demanding and may be related with significant morbidity, if its resection is associated with a vascular injury or important brain invasion. Therefore, the authors believe that an increased number of preoperative imaging studies will be performed in those lesions within the Sylvian fissure to increase the safety of the resection. On the other hand, in those cases where a subtotal resection is performed, postoperative radiotherapy should be considered.

Patient consent

The patient has given written consent for publication of this case report.
  25 in total

Review 1.  Deep sylvian meningioma: a case report and review of literature.

Authors:  G Samson Sujit Kumar; Vedantam Rajshekhar
Journal:  Childs Nerv Syst       Date:  2008-08-19       Impact factor: 1.475

2.  Case report: Sylvian fissure meningioma without dural attachment in a 4-year-old child.

Authors:  J R Cooper; L A Marshman; C M Smith; T Powell
Journal:  Clin Radiol       Date:  1997-11       Impact factor: 2.350

3.  Staged surgery for sylvian fissure meningiomas without dural attachment: report of two cases.

Authors:  Yavuz Aras; Mehmet Osman Akcakaya; Aydin Aydoseli; Nail Izgi
Journal:  Clin Neurol Neurosurg       Date:  2013-01-03       Impact factor: 1.876

Review 4.  [Left Sylvian fissure meningioma in a one-year-eight-month old child].

Authors:  T Mitsuyama; H Kasuya; O Kubo; K Hirasawa; T Hori
Journal:  No Shinkei Geka       Date:  2000-05

Review 5.  Epidemiology of intracranial meningioma.

Authors:  Elizabeth B Claus; Melissa L Bondy; Joellen M Schildkraut; Joseph L Wiemels; Margaret Wrensch; Peter M Black
Journal:  Neurosurgery       Date:  2005-12       Impact factor: 4.654

6.  Deep sylvian meningioma in a child.

Authors:  B K Cho; K C Wang; K H Chang; J G Chi
Journal:  Childs Nerv Syst       Date:  1990-06       Impact factor: 1.475

7.  [A case of deep sylvian meningioma with intracerebral hematoma (author's transl)].

Authors:  T Tsuchida; J Ito; K Sekiguchi; H Honda; K Ueki
Journal:  No Shinkei Geka       Date:  1981

8.  Deep Sylvian meningiomas.

Authors:  S Okamoto; H Handa; J Yamashita; Y Tokuriki
Journal:  Surg Neurol       Date:  1985-03

Review 9.  Modern meningioma imaging techniques.

Authors:  D Saloner; A Uzelac; S Hetts; A Martin; W Dillon
Journal:  J Neurooncol       Date:  2010-09-01       Impact factor: 4.130

10.  [A case of deep sylvian meningioma (author's transl)].

Authors:  S Mori; H Ishihara; T Sogabe; Y Kodama; H Hibino
Journal:  No Shinkei Geka       Date:  1977-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.